Portugal INFARMED

Akeega (niraparib + abiraterone): public funding assessment report available; approval granted

Original title: Akeega (Niraparib+abiraterona) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento

Portugal's INFARMED has approved public funding for Akeega (niraparib + abiraterone) following completion of the funding evaluation report.

Low obligation Product class Pharmaceuticals Market Access & Reimbursement Portugal Reimbursement

Data : 03/08/2026

Dates and deadlines

Applies from

2026-08-03

Read the official source ↗

Published by Portugal INFARMED. HealthSignal links to the original document; the summary above is extracted from the source text.